среда, 16 апреля 2008 г.

Oramed begins studies on its oral insulin capsule at hadassah medical center

Phase 2A trial is focused on assessing the safety and efficacy of the oral insulin capsule on 10 type 2 diabetes patients.Study is a continuation of the recently successfullypleted Phase 1 studies in Israel."We are pleased to have achieved this milestone of beginning Phase 2A clinical trials in Israel in the second quarter of this year," said Nadav Kidron, CEO of Oramed Pharmaceuticals.Have had much success with our past clinical trials, and are on schedule with reaching our planned milestones and hope that Oramed's oral insulin capsule will succeed in revolutionizing the current treatment for diabetes.ABOUT ORAMED PHARMACEUTICALS Oramed Pharmaceuticals is an Israeli-basedpany focused on the development of oral delivery solutions based on proprietary technology.Is one of the most rapidly growing diseases in the world and is one that requires constant and often unpleasant monitoring and drug therapy regimens.Is currently developing an orally ingestible insulin capsule for the treatment of diabetes.Also pursuing the development of oral delivery solutions for other drugs and vaccines.STATEMENTS Some of the statements contained in this press release are forward- looking statements which involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of thepany, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates;petition from other pharmaceutical or biotechnologypanies; and thepany's ability to obtain additional funding required to conduct its research, development andmercialization activities.Refer to thepany's filings with the Securities and Exchangemission for aprehensive list of risk factors that could cause actual results, performance or achievements of thepany to differ materially from those expressed or implied in such forward looking statements.Undertakes no obligation to update or revise any forward-looking statements.PLEASE RATE THIS ARTICLE: (Hover over the stars then click to rate) PATIENT / PUBLIC: OR HEALTH PROFESSIONAL: USEFUL LINKS ADD TO: CONTACT OUR NEWS EDITORS For any corrections of factual information, or to contact the editors please use our .Send any medical news or health news press releases to: 2008 News Category Menu News By Email Navigation Links Health Professional Sites Patient Resource Sites Clinical Trials For Health Professionals Latest News For Diabetes 16 Apr 2008 16 Apr 2008 15 Apr 2008 Latest Videos for Diabetes There may be another thing that people with diabetes need to take care of: their balance.Some balance exercises and learn what you can do to keep on your feet.
Read more Obesity Raises Cancer Risk (HealthDay)
Get more High cost of keeping up with yummy mummies